山东大学学报 (医学版) ›› 2022, Vol. 60 ›› Issue (5): 87-97.doi: 10.6040/j.issn.1671-7554.0.2022.0500
高琳1,于鑫鑫2,康冰2,张帅1,王锡明1
GAO Lin1, YU Xinxin2, KANG Bing2, ZHANG Shuai1, WANG Ximing1
摘要: 目的 评估从平扫CT及增强CT图像中提取的组学特征是否能提高对纯磨玻璃结节(pGGNs)组织学浸润性的鉴别能力,建立诺模图协助预测pGGNs的浸润性。 方法 回顾性分析山东第一医科大学附属省立医院2018年12月至2021年6月332例患者,共364个pGGN,按照病理类型分为前驱病变组[包括不典型腺瘤样增生(AAH)和原位腺癌(AIS),共157个]和浸润性病变组[包括微浸润性腺癌(MIA)和浸润性腺癌(IAC),共207个]。在平扫和增强图像上勾画感兴趣区域(ROI)并提取特征。运用最小绝对收缩选择算子(LASSO)进行特征筛选,并对筛选出的放射组学特征进行线性拟合,根据各自加权系数,生成放射组学得分(Rad-score)。将临床资料和CT形态学特征作为临床特征进行多因素回归分析筛选独立预测因子建立临床因素模型。采用多元逻辑回归的方法结合放射组学模型和临床因素模型,构建诺模图。通过受试者操作特性曲线(ROC)、校正曲线和决策曲线(DCA)评估诺模图性能。 结果 三期(包括平扫、动脉期和静脉期)融合放射组学模型在训练集和验证集中预测pGGN浸润性的AUC是0.915和0.841,显著高于平扫(0.882, 0.796)、动脉期(0.884, 0.814)、静脉期(0.897, 0.841)组学模型、以及临床因素模型(0.805,0.747)。结合三期融合模型及临床因素构建的诺模图 AUC值为0.928(训练集)和0.854(验证集),优于组学模型及临床因素模型。 结论 增强CT图像提取的影像组学特征可提高对pGGNs浸润性的鉴别能力,诺模图可更好地预测pGGNs的浸润性。
中图分类号:
| [1] Li M, Narayan V, Gill RR, et al. Computer-aided diagnosis of ground-glass opacity nodules using open-source software for quantifying tumor heterogeneity [J]. Am J Roentgenol, 2017, 209(6): 1216-1227. [2] Mei X, Wang R, Yang W, et al. Predicting malignancy of pulmonary ground-glass nodules and their invasiveness by random forest [J]. J Thorac Dis, 2018, 10(1): 458-463. [3] Zappa C, Mousa SA. Non-small cell lung cancer: current treatment and future advances [J]. Transl Lung Cancer Res, 2016, 5(3): 288-300. [4] Li Q, Fan L, Cao ET, et al. Quantitative CT analysis of pulmonary pure ground-glass nodule predicts histological invasiveness [J]. Eur J Radiol, 2017, 89: 67-71. doi: 10.1016/j.ejrad.2017.01.024. [5] Wu F, Tian SP, Jin X, et al. CT and histopathologic characteristics of lung adenocarcinoma with pure ground-glass nodules 10 mm or less in diameter [J]. Eur Radiol, 2017, 27(10): 4037-4043. [6] World Health Organization(2021). WHO classification of tumours of the lung [EB/OL].(2021-01)[2021-05-10]. https://tumourclassification.iarc.who.int. [7] Eisenberg RL, Bankier AA, Boiselle PM. Compliance with Fleischner Society Guidelines for management of small lung nodules: a survey of 834 radiologists [J]. Radiology, 2010, 255(1): 218-224. [8] Song L, Xing T, Zhu Z, et al. Hybrid clinical-radiomics model for precisely predicting the invasiveness of lung adenocarcinoma manifesting as pure ground-glass nodule [J]. Acad Radiol, 2021, 28(9): e267-e277. [9] Yagi T, Yamazaki M, Ohashi R, et al. HRCT texture analysis for pure or part-solid ground-glass nodules: distinguishability of adenocarcinoma in situ or minimally invasive adenocarcinoma from invasive adenocarcinoma [J]. Jpn J Radiol, 2018, 36(2): 113-121. [10] She Y, Zhao L, Dai C, et al. Preoperative nomogram for identifying invasive pulmonary adenocarcinoma in patients with pure ground-glass nodule: a multi-institutional study [J]. Oncotarget, 2017, 8(10): 17229-17238. [11] Dai J, Shi J, Soodeen-Lalloo AK, et al. Air bronchogram: a potential indicator of epidermal growth factor receptor mutation in pulmonary subsolid nodules [J]. Lung Cancer, 2016, 98: 22-28. doi: 10.1016/j.lungcan.2016.05.009. [12] Oudkerk M, Devaraj A, Vliegenthart R, et al. European position statement on lung cancer screening [J]. Lancet Oncol, 2017, 18(12): e754-e766. [13] White CS, Dharaiya E, Campbell E, et al. The vancouver lung cancer risk prediction model: assessment by using a subset of the national lung screening trial cohort [J]. Radiology, 2017, 283(1): 264-272. [14] Zhan Y, Peng X, Shan F, et al. Attenuation and morphologic characteristics distinguishing a ground-glass nodule measuring 5-10 mm in diameter as invasive lung adenocarcinoma on thin-slice CT [J]. Am J Roentgenol, 2019, 213(4): W162-W170. [15] Lee HW, Jin KN, Lee JK, et al. Long-term follow-up of ground-glass nodules after 5 years of stability [J]. J Thorac Oncol, 2019, 14(8): 1370-1377. [16] 陈琦, 杨文广, 郁义星, 等. 肺部单发微小磨玻璃结节内部血管及支气管改变对肺腺癌侵袭性的诊断预测价值[J]. 临床放射学杂志, 2019, 38(12): 2322-2327. CHEN Qi, YANG Wenguang, YU Yixing, et al. Diagnostic and prognostic value of pulmonary adenocarcinoma invasivity due to vascular and bronchial changes in single microground glass nodules [J]. Journal of Clinical Radiology, 2019, 38(12): 2322-2327. [17] 任开明, 赵俊刚, 林爱军, 等. 肺磨玻璃结节的CT影像特征与病理分类的对照分析研究[J]. 中国临床医学影像杂志, 2019, 30(8): 558-561. REN Kaiming, ZHAO Jungang, LIN Aijun, et al. Comparison analysis of CT image characteristics and pathological classification of pulmonary ground glass nodules [J]. Chinese Journal of Clinical Medical Imaging, 2019, 30(8): 558-561. [18] Gao F, Sun Y, Zhang G, et al. CT characterization of different pathological types of subcentimeter pulmonary ground-glass nodular lesions [J]. Br J Radiol, 2019, 92(1094): 20180204. doi: 10.1259/bjr.20180204. [19] Cho HH, Lee G, Lee HY, et al. Marginal radiomics features as imaging biomarkers for pathological invasion in lung adenocarcinoma [J]. Eur Radiol, 2020, 30(5): 2984-2994. [20] Xu F, Zhu W, Shen Y, et al. Radiomic-based quantitative CT analysis of pure ground-glass nodules to predict the invasiveness of lung adenocarcinoma [J]. Front Oncol, 2020, 10: 872. doi:10.3389/fonc.2020.00872. [21] Wu G, Woodruff HC, Shen J, et al. Diagnosis of invasive lung adenocarcinoma based on chest CT radiomic features of part-solid pulmonary nodules: a multicenter study [J]. Radiology, 2020, 297(2): 451-458. [22] Wu L, Gao C, Xiang P, et al. CT-imaging based analysis of invasive lung adenocarcinoma presenting as ground glass nodules using peri- and intra-nodular radiomic features [J]. Front Oncol, 2020, 10: 838. doi:10.3389/fonc.2020.00838. [23] Liu CL, Zhang F, Cai Q, et al. Establishment of a predictive model for surgical resection of ground-glass nodules [J]. J Am Coll Radiol, 2019, 16(4 Pt A): 435-445. [24] Xue X, Yang Y, Huang Q, et al. Use of a radiomics model to predict tumor invasiveness of pulmonary adenocarcinomas appearing as pulmonary ground-glass nodules [J]. Biomed Res Int, 2018, 2018: 6803971. doi:10.1155/2018/6803971. [25] Li H, Gao L, Ma H, et al. Radiomics-based features for prediction of histological subtypes in central lung cancer [J]. Front Oncol, 2021, 11: 658887 [26] Nie P, Yang G, Guo J, et al. A CT-based radiomics nomogram for differentiation of focal nodular hyperplasia from hepatocellular carcinoma in the non-cirrhotic liver [J]. Cancer Imaging, 2020, 20(1): 20. [27] Nie P, Yang G, Wang Z, et al. A CT-based radiomics nomogram for differentiation of renal angiomyolipoma without visible fat from homogeneous clear cell renal cell carcinoma [J]. Eur Radiol, 2020, 30(2): 1274-1284. [28] 杨蕾, 张在先, 国建林, 等. 基于增强CT影像组学模型预测肺腺癌ALK突变[J]. 中国医学影像学杂志, 2021, 29(5): 454-458. YANG Lei, ZHANG Zaixian, GUO Jianlin, et al. Prediction of ALK mutation in lung adenocarcinoma based on enhanced CT imaging omics model [J]. Chinese Journal of Medical Imaging, 2021, 29(5): 454-458. [29] Cong M, Feng H, Ren JL, et al. Development of a predictive radiomics model for lymph node metastases in pre-surgical CT-based stage IA non-small cell lung cancer [J]. Lung Cancer, 2020, 139: 73-79. doi: 10.1016/j.lungcan.2019.11.003 [30] Son JY, Lee HY, Kim JH, et al. Quantitative CT analysis of pulmonary ground-glass opacity nodules for distinguishing invasive adenocarcinoma from non-invasive or minimally invasive adenocarcinoma: the added value of using iodine mapping [J]. Eur Radiol, 2016, 26(1): 43-54. [31] Yi CA, Lee KS, Kim EA, et al. Solitary pulmonary nodules: dynamic enhanced multi-detector row CT study and comparison with vascular endothelial growth factor and microvessel density [J]. Radiology, 2004, 233(1): 191-199. [32] Gao C, Xiang P, Ye J, et al. Can texture features improve the differentiation of infiltrative lung adenocarcinoma appearing as ground glass nodules in contrast-enhanced CT? [J]. Eur J Radiol, 2019, 117: 126-131. doi: 10.1016/j.ejrad.2019.06.010. |
| [1] | 吕艳锋 丁克 王建新 禹化龙 贝绍生. 慢性肛瘘癌变诊疗分析[J]. 山东大学学报(医学版), 2209, 47(6): 55-57. |
| [2] | 梁晨,姚丽娟,吕龙飞,唐泽,秦达,崔有斌,余孝淇. 三维重建联合CT引导下穿刺定位在微创治疗肺磨玻璃结节中的应用[J]. 山东大学学报 (医学版), 2026, 64(5): 74-82. |
| [3] | 李儆修,李忠慧,李闻天,王宇男,宋泽辉,庄大勇,贺青卿,周鹏. 光电检测仪在甲状腺癌术中的初步应用[J]. 山东大学学报 (医学版), 2026, 64(4): 31-37. |
| [4] | 陆晨琳,许露,杨俊发,潘华琴,倪清涛. 基于动态列线图及机器学习的慢性阻塞性肺疾病急性加重期伴发肺性脑病风险预测模型构建及验证[J]. 山东大学学报 (医学版), 2026, 64(3): 108-115. |
| [5] | 黄佩文, 王旭东. 治疗非小细胞肺癌新药:靶向c-Met蛋白的抗体药物偶联物Telisotuzumab Vedotin[J]. 山东大学学报 (医学版), 2026, 64(3): 124-130. |
| [6] | 殷悦,莫振飞,吴培昕,刘金霞,魏元辉,任佳博,李春笋. GPX1基因在肺癌中的表达特征及其对肺腺癌细胞增殖、迁移、侵袭、凋亡的影响[J]. 山东大学学报 (医学版), 2026, 64(1): 65-73. |
| [7] | 古春青,郭睿思,周勤勤,刘恒辉,巴婉玉,孙士玲,王冰,郑玉玲,吴宿慧. 基于网络药理学和动物实验探讨酸枣仁-远志药对治疗乳腺癌相关性失眠的作用机制[J]. 山东大学学报 (医学版), 2026, 64(1): 99-108. |
| [8] | 韩觉明,王晖,吴倩,郑慧玲,朱琳. B4GALNT4促进肺腺癌细胞增殖、迁移和侵袭能力[J]. 山东大学学报 (医学版), 2025, 63(7): 23-31. |
| [9] | 沈薇,金晨曦,李娜,李潇旋,郭泾. 儿童三维颅颌面及上气道结构与呼吸暂停低通气指数的相关性[J]. 山东大学学报 (医学版), 2025, 63(7): 44-53. |
| [10] | 刘保国,宋翔,赵晓文,毛亚丽. 血清STAT5B、NKAIN1 mRNA检测在乳腺癌中的应用价值[J]. 山东大学学报 (医学版), 2025, 63(7): 68-74. |
| [11] | 葛雪,赵红艳. 疱疹病毒感染对重症肺炎患者临床预后及呼吸道微生态的影响[J]. 山东大学学报 (医学版), 2025, 63(6): 27-37. |
| [12] | 曹洛菲,王珊珊,王金荣,姜荷云,苗瑜,马光增. 哮喘发作期FeNO升高儿童肺功能舒张试验的特点分析[J]. 山东大学学报 (医学版), 2025, 63(6): 38-44. |
| [13] | 王雪梅,杨豪,宋洋,程世超,张婷婷,王艳春. 抗糖尿病药物与女性恶性肿瘤的因果关联:一项两样本孟德尔随机化分析[J]. 山东大学学报 (医学版), 2025, 63(6): 67-77. |
| [14] | 祝永才,谢艳,齐秋晨,李培龙,王传新,杜鲁涛. 基于外周血单个核细胞ATM基因甲基化的联合模型在胰腺癌早期诊断中的价值[J]. 山东大学学报 (医学版), 2025, 63(6): 78-88. |
| [15] | 赵志敏,王春,李白翎. del Nido停搏液在心脏外科的应用:过去、现在与未来[J]. 山东大学学报 (医学版), 2025, 63(5): 54-59. |
|
||